Back To Search Results

Neurogenic Pulmonary Edema

Editor: Sandeep Sharma Updated: 5/4/2025 11:00:15 PM

Introduction

Neurogenic pulmonary edema is a clinical condition that results from a severe neurological injury and is manifest as acute respiratory distress. By definition, this condition is characterized by the acute development of a significant accumulation of extravascular pulmonary fluid following a severe central nervous system (CNS) insult, most commonly to the brainstem. Shanahan was the first to describe acute neurogenic pulmonary edema in 1908.

Neurogenic pulmonary edema requires the exclusion of other identifiable pulmonary lesions or sources of cardiovascular impairment that may accompany nervous system compromise, such as pulmonary aspiration or other ischemic, toxic, or traumatic lesions of the heart or lungs.

If the clinical presentation is unequivocal, the diagnosis should be presumed when acute pulmonary edema is associated with CNS injury in the absence of primary pulmonary or cardiovascular damage. However, some ambiguity may still persist, particularly because the exact pathogenesis of neurogenic pulmonary edema is not fully understood, as described in the literature.[1][2][3]

Etiology

Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care

Etiology

Any acute CNS injury may result in neurogenic pulmonary edema. However, the 3 most common causes of this syndrome are open or closed cranial trauma, subarachnoid hemorrhage following aneurysmal rupture in more than 50% of cases, and epilepsy with generalized seizures.[4][5] Neurogenic pulmonary edema has also been reported in other pathological situations, eg, stroke, cervical medullary trauma, after intracranial surgery, and in meningitis.[6]

The occurrence of neurogenic pulmonary edema in a brain-injured patient is usually associated with a poor prognosis, where the mortality rate is as high as 60% to 100%. Mortality is attributed to both the pulmonary involvement and the primary brain injury.[2][3][7]

Epidemiology

The actual incidence of neurogenic pulmonary edema remains unknown. However, through pathological data analysis, experts have proposed that the condition is usually present at autopsy in patients who die immediately after a seizure and also in victims of severe head injury. Overall, the cases of neurogenic pulmonary edema are rare, with only 20% of serious head injury patients having the condition.[8][9][10][11]

Pathophysiology

A comprehensive understanding of the pathophysiology of neurogenic pulmonary edema remains uncertain.

The CNS disturbance will cause a sympathetic overflow, leading to a state of systemic vasoconstriction. This process directs blood from the systemic circulation into the pulmonary circulation, thereby increasing the pulmonary capillary hydrostatic pressure. That change in pressure will result in the leakage of intravascular fluid into both the alveoli and the pulmonary interstitial space through the following 2 mechanisms:

  • A change in the pressure across the alveolar bed as a result of Starling forces
  • A change in the permeability of the capillary walls

For a complete, comprehensive understanding of the pathophysiology of neurogenic pulmonary edema, clinicians should consider 3 different sectors: the central, autonomic, and cardiovascular and pulmonary systems. However, the fact that this clinical condition results from the overlapping of these sectors through cause and effect is worth noting.

Central Nervous System

Structural considerations

The injured CNS will initiate a state of sympathetic overactivity. Specific centers in the CNS, when stimulated, will result in activation of the autonomic sympathetic system. Centers responsible for autonomic contributions to the pathogenesis of neurogenic pulmonary edema are located in specific areas of the CNS that elicit neurogenic pulmonary edema. These areas are located in the rostral ventrolateral medulla, area postrema, nuclei of the solitary tract, nuclei of A1 and A5, the medial reticulated nucleus, and the dorsal motor vagus nucleus.

Chemical processes

The role of neurotransmitters in the pathogenesis of neurogenic pulmonary edema is unclear. Experimental studies have shown that the activity of NMDA receptors and GABA receptors in neurogenic pulmonary edema influences sympathetic flow following a CNS insult.

Physiological events

Increased intracranial pressure (ICP) is a common occurrence after CNS injury. The abrupt increase in ICP will result in the Cushing triad of hypertension, irregular breathing, and bradycardia. These physiological changes, along with sympathetic overflow, promote the development of pulmonary edema. Experimental studies in animals have demonstrated an increase in pulmonary artery pressure and an increase in extravascular pulmonary fluid volume in response to ICP.

Autonomic Nervous System

Sympathetic overflow

The sympathetic system is the primary driver in the pathogenesis of neurogenic pulmonary edema.[12] The sudden over-activation of the neurogenic pulmonary edema trigger zone, either due to direct injury or irritation, activation of ascending neural pathways, or as a response to the raised ICP will lead to sympathetic overflow and a catecholamine release that initiates 3 important pathophysiological responses; systemic vasoconstriction, hypertension, and an increase in venous return.[13][12] 

Parasympathetic contribution

The tenth cranial nerve, known as the vagus nerve, provides the parasympathetic supply to the lungs and heart. Although the effect of the vagus nerve on the heart during CNS injury is fairly well understood, the correlation between the vagus nerve response and the development of neurogenic pulmonary edema is vigorously debated and lacks clear supporting evidence. Clinicians should also note that the correlation between vagus nerve activity and the pathogenesis of neurogenic pulmonary edema raises the question of whether bradycardia is an essential or an accessory factor in the development of pulmonary edema.

Cardiovascular and Pulmonary Systems

Sympathetic overflow and a catecholamine surge result in an increase in systemic resistance, venous return, and blood pressure. The proposed theories of the development of neurogenic pulmonary edema include:

  • Hemodynamic changes: Increased functional demand on the cardiac muscle due to the previously mentioned outcomes of the sympathetic overflow will cause the movement of blood from the systemic highly resistant circulation to the less resistant pulmonary circulation, increasing the pulmonary capillary positive hydrostatic pressure that results in the movement of fluid from the capillaries into the lung tissue and the interstitial space.
  • Neurogenic myocardial injury: Neurogenic myocardial injury is primarily the result of the sudden catecholamine surge. The increase in systemic blood pressure and venous return will cause a volume overload on the heart. As the left ventricle fails to functionally meet the loading change, accumulation of blood in the ventricle occurs, leading to cardiac damage and diastolic dysfunction. This will lead to pulmonary vascular congestion and subsequent pulmonary edema.
  • Pulmonary capillary permeability: The following 2 possible causes govern increased pulmonary capillary permeability:
    • Direct (humoral): Damage to the pulmonary capillary endothelium in direct response to the catecholamine release, regardless of hemodynamic changes.[14][15][16][17] 
    • Indirect (physical): Damage to the capillary bed as a mechanical response to the abrupt rise in the pulmonary capillary hydrostatic pressure.[18][19][20]

History and Physical

Rapid changes characterize the early stages of neurogenic pulmonary edema. The most common patients are usually children or young adults who have suffered from a recent intracranial injury. In cases of blunt head injuries, neurogenic pulmonary edema may develop within a matter of minutes. No specific symptomatology for neurogenic pulmonary edema has been established. Neurogenic pulmonary edema is most often concomitant with the initial phase of the neurological pathology. The clinical signs are typically indicative of pulmonary edema, with the absence of signs of left ventricular failure, which is generally characteristic of cardiogenic edema. For classic neurogenic pulmonary edema, the manifestation is immediate, and it can be detected clinically within 2 to 12 hours after injury.

The symptomatology is that of any pulmonary edema with initial ventilation disorders, often accompanied by systolic hypertension, probably also testifying to intracranial hypertension. In patients with spontaneous ventilation, early signs include dyspnea, tachypnea, cough, and rales on auscultation, as well as tachycardia, which may be accompanied by pink, foamy sputum or hemoptysis. More discrete symptoms of sympathetic stimulation, including insomnia, sweating, paralytic ileus, and transient hypertension, have also been described. Ventilation and perfusion disorders, hypoxemia, and carbon dioxide retention frequently occur shortly after that.

The natural evolution of neurogenic pulmonary edema leads to respiratory failure, followed by cardiovascular collapse, and has a high mortality that has been estimated at more than 60%. Determining whether the direct cause of this mortality is pulmonary, neurological, or cardiovascular is impossible. In contrast to older descriptions, more recent publications seem to attribute mortality to the brain injury. However, in cases of pediatric encephalomyelitis, the cause of death would be primarily pulmonary or cardiovascular.[2][21][22]

Evaluation

The diagnosis of neurogenic pulmonary edema is clinical and is based on the presence of pulmonary manifestations in patients with a CNS injury. The primary aim of diagnostic studies is to exclude other differential diagnoses.

Radiographic Studies

A chest x-ray is essential for differentiating this condition from aspiration pneumonitis. With aspiration pneumonitis, the radiographic features will evolve over a few hours and can take up to 3 weeks to resolve. This pattern contrasts with the alveolar infiltrates seen in neurogenic pulmonary edema, which typically occur immediately after the injury. Excluding other pulmonary causes, such as lung contusion, hemothorax, and pneumothorax, is necessary to confirm the diagnosis of neurogenic pulmonary edema.

Electrocardiography and Echocardiography

Cardiac assessments, including electrocardiography and echocardiography, help determine whether functional and structural heart abnormalities are present.

Biomarkers

No specific biomarker for neurogenic pulmonary edema has been established. However, clinicians should consider obtaining cardiac enzymes to evaluate cardiac function.[23][24]

Treatment / Management

The evolution of this syndrome is often favorable after 48 to 72 hours of proper treatment, at which point the prognosis will primarily depend on the underlying neurological pathology. All cases of neurogenic pulmonary edema have a high mortality, requiring intensive care. The suspicion of neurogenic pulmonary edema initially requires symptomatic treatment consisting of artificial ventilation and intensive care monitoring. Consideration should be given to continually measuring ICP and possibly capillary pulmonary pressure.

Management should provide causal treatment, which can often be difficult in severe head trauma. The primary goal in managing diffuse injury to the CNS is to reduce ICP. Based on current pathophysiological hypotheses, cardiovascular therapy aims to increase the inotropic response through beta-adrenergic stimulation, and reducing pulmonary vascular resistance is essential. Nitric oxide, used for this purpose, is experimental but may have beneficial effects.

In the later stages of neurogenic pulmonary edema, the cardiovascular and ventilation strategies used in acute respiratory distress syndrome (ARDS) will be required.[25] The administration of steroids remains controversial.[26][27][28](A1)

Differential Diagnosis

Differential diagnoses that should also be considered when evaluating a patient with suspected neurogenic pulmonary edema include:

  • Adult respiratory distress syndrome
  • Aspiration pneumonitis and pneumonia
  • Bacterial pneumonia
  • Cardiogenic pulmonary edema
  • Subarachnoid hemorrhage

Prognosis

The prognosis of neurogenic pulmonary edema is closely tied to the severity of the underlying central nervous system injury rather than the pulmonary condition itself. Although the respiratory manifestations of neurogenic pulmonary edema can be severe, with rapid progression to respiratory failure and cardiovascular collapse, appropriate intensive care and supportive management often lead to significant improvement within 48 to 72 hours.

Despite this potential for recovery, the overall mortality rate remains high, estimated at over 60%, particularly in cases involving extensive brain injury. Outcomes are generally poorer in severe traumatic brain injuries and pediatric encephalomyelitis, where pulmonary and cardiovascular complications contribute significantly to mortality.

Complications

Neurogenic pulmonary edema can lead to several serious complications, primarily stemming from rapid respiratory and cardiovascular deterioration. Acute respiratory failure is a common consequence, often requiring mechanical ventilation and intensive care. Cardiovascular complications, eg, systemic hypertension, neurogenic myocardial injury, and eventual cardiovascular collapse, further worsen the clinical picture.

Hypoxemia and ventilation-perfusion mismatch can develop quickly, exacerbating neurological injury through secondary brain hypoxia. Additionally, the high pulmonary capillary pressures and increased permeability may cause long-term lung injury if not promptly managed. The overlapping impact of pulmonary, cardiac, and neurological dysfunction makes neurogenic pulmonary edema a condition with a high risk of multiorgan failure and death.

Deterrence and Patient Education

Deterrence of neurogenic pulmonary edema primarily focuses on the prompt recognition and management of central nervous system injuries to prevent secondary complications. Early control of intracranial pressure, vigilant cardiovascular monitoring, and immediate supportive respiratory care are essential strategies. Although patient education is limited due to the acute and often sudden nature of neurogenic pulmonary edema, educating families and caregivers about the signs of respiratory distress in patients with recent CNS trauma is essential. Additionally, interprofessional communication among clinicians is critical to ensure timely diagnosis and intervention, ultimately improving outcomes and reducing the risk of severe complications associated with NPE.

Pearls and Other Issues

Key factors that should be kept in mind in the management of neurogenic pulmonary edema include:

  • Cases of fulminant neurogenic pulmonary edema can occur in patients suffering from mouth, foot, and hand diseases.
  • Aspiration pneumonia and neurogenic pulmonary edema are different conditions and require distinct treatments. The focal point of the treatment involves finding a balance between such measures as the reduction in intracranial pressure, body oxygenation optimization, decreasing pre-load and after-load, and improving cardiac contractility.
  • Neurogenic pulmonary edema often occurs for a short time (minutes to 48 hours) after the CNS injury and is mainly manifested by acute respiratory failure. The clinical diagnosis is easy to determine in young patients without a history of cardio-respiratory disorders or direct lesions of these organs. It can be very difficult in poly-trauma patients or older people with pre-existing cardiac or pulmonary insufficiency.
  • Phentolamine, phenoxybenzamine, and other alpha-receptor blocking agents have been tried, and the results were promising.
  • Theoretically, droperidol is preferred, due to its alpha-receptor-blocking properties and the ability to reduce cerebral metabolism. 
  • In cases where severe depression of myocardial function is present, dobutamine has been used to reverse this dysfunction.
  • While fluid restriction and diuretics are good options, there is the need to be verycareful with their applications, because some patients may be hypovolemic.

Enhancing Healthcare Team Outcomes

The diagnosis and management of neurogenic pulmonary edema require a high level of clinical skill and interprofessional collaboration, given the condition’s ability to mimic other pulmonary pathologies and the absence of a specific diagnostic marker. Physicians, including internists, cardiologists, intensivists, pulmonologists, and nephrologists, must apply strong clinical judgment to differentiate neurogenic pulmonary edema from conditions such as aspiration pneumonia, pulmonary embolism, or primary cardiac dysfunction. Advanced practitioners play an essential role in the early identification of respiratory distress and in initiating appropriate diagnostic workups. Nurses are critical for continuous bedside monitoring, recognizing subtle changes in neurological or respiratory status, and ensuring timely interventions. Pharmacists contribute by guiding safe medication use, particularly in the judicious administration of diuretics, considering that many patients may be hypovolemic and require careful fluid management rather than aggressive diuresis.

Effective interprofessional communication and coordinated care strategies are key to enhancing patient-centered care, improving outcomes, ensuring patient safety, and optimizing team performance in managing neurogenic pulmonary edema. Real-time sharing of clinical findings and collaborative treatment planning are crucial for avoiding delays in diagnosis and ensuring comprehensive care, which encompasses not only respiratory and cardiovascular support but also the prevention of secondary complications, such as deep vein thrombosis and pressure ulcers. Each professional must understand their specific responsibilities and maintain open channels of communication to adjust treatment as the patient’s condition evolves. Coordinated, interprofessional efforts enable a holistic management plan that addresses the primary neurological injury, optimizes cardiopulmonary function, and reduces the risk of morbidity and mortality, ultimately achieving better recovery trajectories for patients with neurogenic pulmonary edema.

References


[1]

Kennedy JD, Hardin KA, Parikh P, Li CS, Seyal M. Pulmonary edema following generalized tonic clonic seizures is directly associated with seizure duration. Seizure. 2015 Apr:27():19-24     [PubMed PMID: 25844030]


[2]

Raja HM, Herwadkar AV, Paroutoglou K, Lilleker JB. Neurogenic pulmonary oedema complicating a lateral medullary infarct. BMJ case reports. 2018 Jul 26:2018():. pii: bcr-2018-225437. doi: 10.1136/bcr-2018-225437. Epub 2018 Jul 26     [PubMed PMID: 30054324]

Level 3 (low-level) evidence

[3]

Romero Osorio OM, Abaunza Camacho JF, Sandoval Briceño D, Lasalvia P, Narino Gonzalez D. Postictal neurogenic pulmonary edema: Case report and brief literature review. Epilepsy & behavior case reports. 2018:9():49-50. doi: 10.1016/j.ebcr.2017.09.003. Epub 2017 Sep 28     [PubMed PMID: 29692972]

Level 3 (low-level) evidence

[4]

Miyahara M, Osaki K. Neurogenic pulmonary oedema and haemorrhage in childhood epileptic seizures: A case report and literature review. Journal of paediatrics and child health. 2023 Mar:59(3):577-579. doi: 10.1111/jpc.16382. Epub 2023 Feb 15     [PubMed PMID: 36789585]

Level 3 (low-level) evidence

[5]

Guo L, Yang X, Yang B, Tang G, Li C. Prevalence, in-hospital mortality, and factors related to neurogenic pulmonary edema after spontaneous subarachnoid hemorrhage: a systematic review and meta-analysis. Neurosurgical review. 2023 Jul 11:46(1):169. doi: 10.1007/s10143-023-02081-6. Epub 2023 Jul 11     [PubMed PMID: 37432487]

Level 1 (high-level) evidence

[6]

Zhao J, Xuan NX, Cui W, Tian BP. Neurogenic pulmonary edema following acute stroke: The progress and perspective. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2020 Oct:130():110478. doi: 10.1016/j.biopha.2020.110478. Epub 2020 Jul 30     [PubMed PMID: 32739737]

Level 3 (low-level) evidence

[7]

Felman AH. Neurogenic pulmonary edema. Observations in 6 patients. The American journal of roentgenology, radium therapy, and nuclear medicine. 1971 Jun:112(2):393-6     [PubMed PMID: 5581250]


[8]

Simmons RL, Martin AM Jr, Heisterkamp CA 3rd, Ducker TB. Respiratory insufficiency in combat casualties. II. Pulmonary edema following head injury. Annals of surgery. 1969 Jul:170(1):39-44     [PubMed PMID: 5789528]


[9]

Holland MC, Mackersie RC, Morabito D, Campbell AR, Kivett VA, Patel R, Erickson VR, Pittet JF. The development of acute lung injury is associated with worse neurologic outcome in patients with severe traumatic brain injury. The Journal of trauma. 2003 Jul:55(1):106-11     [PubMed PMID: 12855888]


[10]

Bratton SL, Davis RL. Acute lung injury in isolated traumatic brain injury. Neurosurgery. 1997 Apr:40(4):707-12; discussion 712     [PubMed PMID: 9092843]

Level 2 (mid-level) evidence

[11]

Atkinson JL. Acute lung injury in isolated traumatic brain injury. Neurosurgery. 1997 Nov:41(5):1214-6     [PubMed PMID: 9361081]

Level 3 (low-level) evidence

[12]

Yang A, Liu B, Inoue T. Role of autonomic system imbalance in neurogenic pulmonary oedema. The European journal of neuroscience. 2022 Mar:55(6):1645-1657. doi: 10.1111/ejn.15648. Epub 2022 Mar 20     [PubMed PMID: 35277906]


[13]

Maslonka MA, Sheehan KN, Datar SV, Vachharajani V, Namen A. Pathophysiology and Management of Neurogenic Pulmonary Edema in Patients with Acute Severe Brain Injury. Southern medical journal. 2022 Oct:115(10):784-789. doi: 10.14423/SMJ.0000000000001457. Epub     [PubMed PMID: 36191916]


[14]

Kerr NA, de Rivero Vaccari JP, Abbassi S, Kaur H, Zambrano R, Wu S, Dietrich WD, Keane RW. Traumatic Brain Injury-Induced Acute Lung Injury: Evidence for Activation and Inhibition of a Neural-Respiratory-Inflammasome Axis. Journal of neurotrauma. 2018 Sep 1:35(17):2067-2076. doi: 10.1089/neu.2017.5430. Epub 2018 Jun 8     [PubMed PMID: 29648974]


[15]

Lou M, Chen X, Wang K, Xue Y, Cui D, Xue F. Increased intracranial pressure is associated with the development of acute lung injury following severe traumatic brain injury. Clinical neurology and neurosurgery. 2013 Jul:115(7):904-8. doi: 10.1016/j.clineuro.2012.09.001. Epub 2012 Sep 23     [PubMed PMID: 23010612]


[16]

Colice GL. Neurogenic pulmonary edema. Clinics in chest medicine. 1985 Sep:6(3):473-89     [PubMed PMID: 3907948]

Level 3 (low-level) evidence

[17]

Simon RP. Neurogenic pulmonary edema. Neurologic clinics. 1993 May:11(2):309-23     [PubMed PMID: 8316188]

Level 3 (low-level) evidence

[18]

Ducker TB, Simmons RL. Increased intracranial pressure and pulmonary edema. 2. The hemodynamic response of dogs and monkeys to increased intracranial pressure. Journal of neurosurgery. 1968 Feb:28(2):118-23     [PubMed PMID: 4966167]

Level 3 (low-level) evidence

[19]

Bahloul M, Chaari AN, Kallel H, Khabir A, Ayadi A, Charfeddine H, Hergafi L, Chaari AD, Chelly HE, Ben Hamida C, Rekik N, Bouaziz M. Neurogenic pulmonary edema due to traumatic brain injury: evidence of cardiac dysfunction. American journal of critical care : an official publication, American Association of Critical-Care Nurses. 2006 Sep:15(5):462-70     [PubMed PMID: 16926367]


[20]

Mayer SA, Lin J, Homma S, Solomon RA, Lennihan L, Sherman D, Fink ME, Beckford A, Klebanoff LM. Myocardial injury and left ventricular performance after subarachnoid hemorrhage. Stroke. 1999 Apr:30(4):780-6     [PubMed PMID: 10187879]

Level 2 (mid-level) evidence

[21]

Bean JW, Beckman DL. Centrogenic pulmonary pathology in mechanical head injury. Journal of applied physiology. 1969 Dec:27(6):807-12     [PubMed PMID: 5353203]

Level 3 (low-level) evidence

[22]

Hall A, O'Kane R. The Extracranial Consequences of Subarachnoid Hemorrhage. World neurosurgery. 2018 Jan:109():381-392. doi: 10.1016/j.wneu.2017.10.016. Epub 2017 Oct 16     [PubMed PMID: 29051110]


[23]

Kitagawa T, Yamamoto J, Kureshima M, Maeda H, Nishizawa S. [Takotsubo Cardiomyopathy and Neurogenic Pulmonary Edema Following Fibrinolytic Therapy for Embolic Stroke:A Case Report]. No shinkei geka. Neurological surgery. 2018 Jan:46(1):21-25. doi: 10.11477/mf.1436203669. Epub     [PubMed PMID: 29362281]

Level 3 (low-level) evidence

[24]

Bonello M, Pullicino R, Larner AJ. Acute pulmonary oedema: not always cardiogenic. The journal of the Royal College of Physicians of Edinburgh. 2017 Mar:47(1):57-59. doi: 10.4997/JRCPE.2017.112. Epub     [PubMed PMID: 28569284]


[25]

Fan TH, Huang M, Gedansky A, Price C, Robba C, Hernandez AV, Cho SM. Prevalence and Outcome of Acute Respiratory Distress Syndrome in Traumatic Brain Injury: A Systematic Review and Meta-Analysis. Lung. 2021 Dec:199(6):603-610. doi: 10.1007/s00408-021-00491-1. Epub 2021 Nov 15     [PubMed PMID: 34779897]

Level 1 (high-level) evidence

[26]

SARNOFF SJ, BERGLUND E, SARNOFF LC. Neurohemodynamics of pulmonary edema. III. Estimated changes in pulmonary blood volume accompanying systemic vasoconstriction and vasodilation. Journal of applied physiology. 1953 Jan:5(7):367-74     [PubMed PMID: 13022604]


[27]

Horton JM. The anaesthetist's contribution to the care of head injuries. British journal of anaesthesia. 1976 Aug:48(8):767-71     [PubMed PMID: 779815]


[28]

Herbst C, Tippler B, Shams H, Simmet T. A role for endothelin in bicuculline-induced neurogenic pulmonary oedema in rats. British journal of pharmacology. 1995 Jul:115(5):753-60     [PubMed PMID: 8548173]

Level 3 (low-level) evidence